Difference between revisions of "Team:SCUT-China/Practices"

(Prototype team page)
 
Line 1: Line 1:
 
{{SCUT-China}}
 
{{SCUT-China}}
 
<html>
 
<html>
 +
<style>
 +
#HPContainer {
 +
width::100%;
 +
margin-top: 63px;
 +
padding: 30px;
 +
}
 +
#HPTitle {
 +
font-size: 80px;
 +
text-align: center;
 +
color: #00b4ed;
 +
padding: 50px 30px 20px 30px;
 +
color:#df2c5a;
 +
margin: 0;
 +
}
 +
#HPContent {
 +
width: 100%;
 +
}
  
−
<h2> Human Practices </h2>
+
.pic_four {
 +
width: 100%;
 +
min-height: 200px;
 +
position: relative;
 +
margin: 20px auto;
 +
}
 +
.pic_four img {
 +
width: 80%;
 +
box-shadow: 0 3px 10px #7d7d7d;
 +
display: block;
 +
border-radius:50%;
 +
margin: 10px auto;
 +
max-width: 330px;
 +
}
 +
.pic_four .pic_a {
 +
position: relative;
 +
left: 0;
 +
width: 25%;
 +
display: inline-block;
 +
}
 +
.pic_four .pic_b {
 +
position: absolute;
 +
left: 25%;
 +
display: inline-block;
 +
width: 25%;
 +
}
 +
.pic_four .pic_c {
 +
position: absolute;
 +
left: 50%;
 +
display: inline-block;
 +
width: 25%;
 +
}
 +
.pic_four .pic_d {
 +
position: absolute;
 +
left: 75%;
 +
display: inline-block;
 +
width: 25%;
 +
}
  
−
<p>iGEM teams are unique and leading the field because they "go beyond the lab" to imagine their projects in a social/environmental context, to better understand issues that might influence the design and use of their technologies.</p>
+
.mind-pic{
−
<p>Teams work with students and advisors from the humanities and social sciences to explore topics concerning ethical, legal, social, economic, safety or security issues related to their work. Consideration of these Human Practices is crucial for building safe and sustainable projects that serve the public interest. </p>
+
width:100%;
−
<p>For more information, please see the <a href="https://2015.igem.org/Practices_Hub">Practices Hub</a>.</p>
+
}
  
−
<div class="highlightBox">
+
.page-link{
−
<h4>Note</h4>
+
display:block;
−
<p>You must fill out this page in order to be considered for all <a href="https://2015.igem.org/Judging/Awards">awards</a> for Human Practices:</p>
+
text-decoration:none;
−
<ul>
+
margin:20px auto;
−
<li>Human Practices silver medal criterion</li>
+
color:#df6b5a;
−
<li>Human Practices gold medal criterion</li>
+
text-align:center;
−
<li>Best Integrated Human Practices award</li>
+
font-size:20px;
−
<li>Best Education and Public Engagement award</li>
+
}
−
</ul>
+
−
</div>
+
  
 +
.page-link:hover{
 +
color:#df6b5a;
 +
}
  
−
<h5>Some Human Practices topic areas </h5>
 
−
<ul>
 
−
<li>Philosophy</li>
 
−
<li>Public Engagement / Dialogue</li>
 
−
<li>Education</li>
 
−
<li>Product Design</li>
 
−
<li>Scale-Up and Deployment Issues</li>
 
−
<li>Environmental Impact</li>
 
−
<li>Ethics</li>
 
−
<li>Safety</li>
 
−
<li>Security</li>
 
−
<li>Public Policy</li>
 
−
<li>Law and Regulation</li>
 
−
<li>Risk Assessment</li>
 
−
</ul>
 
  
−
<h5>What should we write about on this page?</h5>
+
</style>
−
<p>On this page, you should write about the Human Practices topics you considered in your project, and document any special activities you did (such as visiting experts, talking to lawmakers, or doing public engagement).</p>
+
  
 +
<div id="HPContainer">
 +
    <h1 id="HPTitle">Human Practices</h1>
 +
    <div id="HPContent">
 +
        <div class="part">
 +
            <h3 style="color:#00b4ed">Overview</h3>
 +
            <p>According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line. We hope that our work would provide the proof of principle for future gene therapy.</p>
 +
           
 +
        </div>
 +
        <div class="divide-line"></div>
 +
        <div class="part">
 +
        <div class="pic_four">
 +
        <div class="pic_a"><img src="HP/hospital interview.png" /><a class="page-link" href="https://2015.igem.org/Team:SCUT-China/hospitalInterview">Hospital Interview</a></div>
 +
        <div class="pic_b"><img src="HP/conference.png" /><a class="page-link">Conference</a></div>
 +
        <div class="pic_c"><img src="HP/data analyse.png" /><a class="page-link">data analyse</a></div>
 +
        <div class="pic_d"><img src="HP/thinking.png" /><a class="page-link">thinking</a></div>
 +
        </div>
 +
        </div>
 +
        <div class="part">
 +
        <img class="mind-pic" src="HP/HP思维导图3-改4.png"/>
 +
        </div>
 +
    </div>
 +
</div>
  
−
<h5>Inspiration</h5>
 
−
<p>Read what other teams have done:</p>
 
−
<ul>
 
−
<li><a href="https://2014.igem.org/Team:Dundee/policypractice/experts">2014 Dundee </a></li>
 
−
<li><a href="https://2014.igem.org/Team:UC_Davis/Policy_Practices_Overview">2014 UC Davis </a></li>
 
−
<li><a href="https://2013.igem.org/Team:Manchester/HumanPractices">2013 Manchester </a></li>
 
−
<li><a href="https://2013.igem.org/Team:Cornell/outreach">2013 Cornell </a></li>
 
−
</ul>
 
  
−
<h3>Integrated Human Practices</h3>
 
−
 
−
<p>Do you want to be considered for the <a href="https://2015.igem.org/Judging/Awards#SpecialPrizes">Best Integrated Human Practices award</a>? Make it easy for the judges to find any wiki content that is relevant to this prize. Highlight this content with a header or separate section.</p>
 
−
 
−
<h3>Education and Public Engagement</h3>
 
−
 
−
<p>Do you want to be considered for the <a href="https://2015.igem.org/Judging/Awards#SpecialPrizes">Best Education and Public Outreach award</a>? Make it easy for the judges to find any wiki content that is relevant to this prize. Highlight this content with a header or separate section.</p>
 
−
 
−
</div>
 
 
</html>
 
</html>

Revision as of 12:45, 18 September 2015

Loading

Human Practices

Overview

According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line. We hope that our work would provide the proof of principle for future gene therapy.

Hospital Interview
Conference
data analyse
thinking